Official Journal of The Academy of Osseointegration
Clinical and Histologic Evaluation of Human Intrabony Defects Treated with an Enamel Matrix Protein Derivative Combined with a Bovine-Derived Xenograft
Anton Sculean, DMD, Dr Med Dent, MS, PhD/Péter Windisch, DMD/Tibor Keglevich, DMD/Giovanni Carlo Chiantella, DDS, MS/István Gera, DMD, PhD/Nicolaos Donos, DDS, MS, PhD
PMID: 12617368
DOI: 10.11607/prd.00.0509
The purpose of the present case report study was to clinically and histologically evaluate the healing of deep intrabony defects following treatment with either a combination of an enamel matrix protein derivative (EMD) and a bovine-derived xenograft (BDX) or with BDX alone. Three female patients with generalized marginal periodontitis and presenting one advanced intrabony defect each were treated with either a combination of EMD + BDX (two defects) or with BDX alone (one defect). The postoperative healing was uneventful in all three cases. Six months after surgery, a gain of clinical attachment was measured at all treated sites. The histologic examination revealed that all three defects healed with a new connective tissue attachment (ie, new cellular cementum with inserting collagen fibers) and new bone. Most of the BDX particles were surrounded by a bonelike tissue. No direct contact between BDX particles and the root surface (cementum or dentin) was observed. Within their limits, the present data indicate that treatment with either EMD + BDX or with BDX alone may enhance the formation of new connective tissue attachment and new bone in human intrabony defects. (Int J Periodontics Restorative Dent 2003;23:47–55.)
© 2020 Quintessence Publishing Co, Inc |
PRD Home Current Issue Ahead of Print Archive Author Guidelines About |
Submission Form Submit Reprints Permission Advertising |
Quintessence Home Terms of Use Privacy Policy About Us Contact Us Help |